FTL
Basic information
Region (hg38): 19:48965309-48967896
Links
Phenotypes
GenCC
Source:
- hereditary hyperferritinemia with congenital cataracts (Definitive), mode of inheritance: AD
- hereditary hyperferritinemia with congenital cataracts (Strong), mode of inheritance: AD
- L-ferritin deficiency (Strong), mode of inheritance: AD
- neuroferritinopathy (Strong), mode of inheritance: AD
- neuroferritinopathy (Moderate), mode of inheritance: AD
- hereditary hyperferritinemia with congenital cataracts (Moderate), mode of inheritance: AD
- hereditary hyperferritinemia with congenital cataracts (Supportive), mode of inheritance: AD
- neuroferritinopathy (Supportive), mode of inheritance: AD
- genetic hyperferritinemia without iron overload (Supportive), mode of inheritance: AD
- L-ferritin deficiency (Supportive), mode of inheritance: AD
- hereditary hyperferritinemia with congenital cataracts (Strong), mode of inheritance: AD
- L-ferritin deficiency (Limited), mode of inheritance: Unknown
- neuroferritinopathy (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
L-ferritin deficiency; Neurodegeneration with brain iron accumulation 3; Hyperferritinemia with or without cataract | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Hematologic; Neurologic; Ophthalmologic | 7493028; 8558554; 7669675; 11438811; 11703332; 12200611; 12199804; 12746423; 15173247; 15280904; 15099026; 17142829; 18413574; 18854324; 20301320; 22020773; 22278127 ; 22515742; 23940258 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neuroferritinopathy;Hereditary hyperferritinemia with congenital cataracts (8 variants)
- Hereditary hyperferritinemia with congenital cataracts (5 variants)
- not provided (3 variants)
- Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy (1 variants)
- Neuroferritinopathy (1 variants)
- Inborn genetic diseases (1 variants)
- FTL-related disorder (1 variants)
- L-ferritin deficiency, autosomal recessive (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FTL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | 22 | ||||
missense | 46 | 48 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 6 | 2 | 8 | |||
non coding | 36 | 59 | ||||
Total | 10 | 9 | 90 | 27 | 4 |
Highest pathogenic variant AF is 0.00000657
Variants in FTL
This is a list of pathogenic ClinVar variants found in the FTL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-48965312-G-C | Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Uncertain significance (Aug 16, 2022) | ||
19-48965315-C-G | Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Uncertain significance (Dec 18, 2022) | ||
19-48965317-GCGGTCCCGCGGGTCTGTCTCTTGCTTCAA-G | Hereditary hyperferritinemia with congenital cataracts | Pathogenic (Feb 19, 2013) | ||
19-48965318-C-T | Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Uncertain significance (Jan 08, 2024) | ||
19-48965319-G-C | Uncertain significance (Apr 26, 2022) | |||
19-48965319-G-T | Neuroferritinopathy;Hereditary hyperferritinemia with congenital cataracts | Uncertain significance (Oct 02, 2021) | ||
19-48965322-C-A | Neuroferritinopathy • Hereditary hyperferritinemia with congenital cataracts | Uncertain significance (Apr 27, 2017) | ||
19-48965322-C-T | Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Uncertain significance (Jan 16, 2024) | ||
19-48965324-C-G | Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Uncertain significance (Nov 03, 2022) | ||
19-48965324-C-T | Uncertain significance (Jun 01, 2024) | |||
19-48965326-C-T | not specified | Uncertain significance (Nov 21, 2023) | ||
19-48965327-G-A | Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Uncertain significance (Jun 15, 2023) | ||
19-48965329-G-A | Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Uncertain significance (Sep 05, 2023) | ||
19-48965329-GTCTGTC-G | Hereditary hyperferritinemia with congenital cataracts | Pathogenic (Feb 19, 2013) | ||
19-48965330-T-G | - | no classification for the single variant (-) | ||
19-48965331-C-T | Neuroferritinopathy;Hereditary hyperferritinemia with congenital cataracts | Uncertain significance (Jul 26, 2023) | ||
19-48965335-C-G | Neuroferritinopathy • Hereditary hyperferritinemia with congenital cataracts • Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Uncertain significance (Aug 29, 2023) | ||
19-48965338-T-C | Neuroferritinopathy;Hereditary hyperferritinemia with congenital cataracts | Uncertain significance (Nov 16, 2023) | ||
19-48965340-G-A | Hereditary hyperferritinemia with congenital cataracts • FTL-related disorder • Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Pathogenic (Dec 02, 2023) | ||
19-48965340-G-C | Hereditary hyperferritinemia with congenital cataracts • Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy • FTL-related disorder | Pathogenic/Likely pathogenic (Mar 12, 2024) | ||
19-48965340-G-T | Hereditary hyperferritinemia with congenital cataracts • Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy • FTL-related disorder | Pathogenic (Sep 23, 2022) | ||
19-48965341-C-T | Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy • Hereditary hyperferritinemia with congenital cataracts | Pathogenic (Jan 16, 2024) | ||
19-48965342-T-C | Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Likely pathogenic (May 21, 2021) | ||
19-48965344-C-A | Hereditary hyperferritinemia with congenital cataracts • Hereditary hyperferritinemia with congenital cataracts;Neuroferritinopathy | Pathogenic/Likely pathogenic (Sep 17, 2024) | ||
19-48965344-C-T | Hereditary hyperferritinemia with congenital cataracts | Pathogenic (Feb 19, 2013) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FTL | protein_coding | protein_coding | ENST00000331825 | 4 | 1578 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.66e-9 | 0.0178 | 125720 | 0 | 28 | 125748 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.441 | 106 | 94.0 | 1.13 | 0.00000513 | 1158 |
Missense in Polyphen | 11 | 12.858 | 0.85548 | 231 | ||
Synonymous | 0.0635 | 40 | 40.5 | 0.987 | 0.00000233 | 337 |
Loss of Function | -1.51 | 11 | 6.77 | 1.62 | 2.94e-7 | 85 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000605 | 0.000604 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity). {ECO:0000250, ECO:0000269|PubMed:19923220, ECO:0000269|PubMed:20159981}.;
- Disease
- DISEASE: Hyperferritinemia with or without cataract (HRFTC) [MIM:600886]: An autosomal dominant disease characterized by elevated level of ferritin in serum and tissues, and early-onset bilateral cataract. Cataracts may be subclinical in some patients. {ECO:0000269|PubMed:19176363}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurodegeneration with brain iron accumulation 3 (NBIA3) [MIM:606159]: A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. It is characterized by a variety of neurological signs including parkinsonism, ataxia, corticospinal signs, mild non-progressive cognitive deficit and episodic psychosis. It is linked with decreased serum ferritin levels. {ECO:0000269|PubMed:16116125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: L-ferritin deficiency (LFTD) [MIM:615604]: A condition characterized by low levels of ferritin in serum and tissues in the absence of other hematological symptoms. Seizures and mild neuropsychologic impairment may manifest in individuals with complete ferritin deficiency. {ECO:0000269|PubMed:23940258}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Necroptosis - Homo sapiens (human);Mineral absorption - Homo sapiens (human);Ferroptosis - Homo sapiens (human);Nuclear Receptors Meta-Pathway;NRF2 pathway;Golgi Associated Vesicle Biogenesis;Clathrin derived vesicle budding;Neutrophil degranulation;trans-Golgi Network Vesicle Budding;Vesicle-mediated transport;Membrane Trafficking;Innate Immune System;Immune System;Transport of small molecules;Iron uptake and transport;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors
(Consensus)
Recessive Scores
- pRec
- 0.648
Intolerance Scores
- loftool
- 0.791
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.25
Haploinsufficiency Scores
- pHI
- 0.0829
- hipred
- Y
- hipred_score
- 0.541
- ghis
- 0.592
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.955
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ftl1
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- iron ion transport;cellular iron ion homeostasis;intracellular sequestering of iron ion;neutrophil degranulation;iron ion homeostasis;oxidation-reduction process
- Cellular component
- extracellular region;cytoplasm;cytosol;intracellular ferritin complex;membrane;azurophil granule lumen;autolysosome;extracellular exosome
- Molecular function
- ferroxidase activity;iron ion binding;protein binding;ferrous iron binding;ferric iron binding;identical protein binding